SC 13D/A | 2024-03-08 | Spectrum Equity VII, L.P. | GoodRx Holdings, Inc. | 29,825,306 | 24.2% | EDGAR |
SC 13D/A | 2024-03-08 | FRANCISCO PARTNERS IV, L.P. | GoodRx Holdings, Inc. | 46,680,496 | 28.6% | EDGAR |
SC 13G | 2024-02-14 | AMERIPRISE FINANCIAL INC | GoodRx Holdings, Inc. | 7,001,503 | 7.6% | EDGAR |
SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | GoodRx Holdings, Inc. | 8,380,990 | 9.1% | EDGAR |
SC 13G | 2024-02-12 | Rubric Capital Management LP | GoodRx Holdings, Inc. | 5,872,806 | 6.4% | EDGAR |
SC 13G/A | 2024-01-25 | MILLENNIUM MANAGEMENT LLC | GoodRx Holdings, Inc. | 602,934 | 0.7% | EDGAR |
SC 13D/A | 2023-11-21 | Spectrum Equity VII, L.P. | GoodRx Holdings, Inc. | 36,048,589 | 30.9% | EDGAR |
SC 13D/A | 2023-10-27 | Bezdek Trevor | GoodRx Holdings, Inc. | 5,120,852 | 5.5% | EDGAR |
SC 13D/A | 2023-10-27 | Hirsch Douglas Joseph | GoodRx Holdings, Inc. | 5,120,852 | 5.5% | EDGAR |
SC 13D | 2023-08-31 | Hirsch Douglas Joseph | GoodRx Holdings, Inc. | 9,042,037 | 9.8% | EDGAR |
SC 13D | 2023-08-31 | Bezdek Trevor | GoodRx Holdings, Inc. | 9,042,037 | 9.8% | EDGAR |
SC 13G/A | 2023-03-10 | VANGUARD GROUP INC | GoodRx Holdings, Inc. | 8,318,305 | 10.1% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | GoodRx Holdings, Inc. | 7,828,633 | 9.5% | EDGAR |
SC 13G/A | 2023-02-06 | MILLENNIUM MANAGEMENT LLC | GoodRx Holdings, Inc. | 5,318,603 | 6.5% | EDGAR |
SC 13G | 2022-12-16 | MILLENNIUM MANAGEMENT LLC | GoodRx Holdings, Inc. | 4,396,531 | 5.3% | EDGAR |
SC 13G/A | 2022-09-12 | MORGAN STANLEY | GoodRx Holdings, Inc. | 433,902 | 0.5% | EDGAR |
SC 13G/A | 2022-04-11 | MORGAN STANLEY | GoodRx Holdings, Inc. | 18,110,421 | 21.0% | EDGAR |
SC 13G/A | 2022-03-04 | Abdiel Qualified Master Fund LP | GoodRx Holdings, Inc. | 2,510,506 | 2.9% | EDGAR |
SC 13D/A | 2022-02-14 | Idea Men, LLC | GoodRx Holdings, Inc. | 50,164,171 | 38.3% | EDGAR |
SC 13G/A | 2022-02-14 | Bezdek Family Irrevocable Trust | GoodRx Holdings, Inc. | 3,120,000 | 3.7% | EDGAR |